Del.icio.us
Google
Yahoo MyWeb
Facebook
Chiasma Overview
Chiasma creates proprietary oral drug products that lengthen the Life Cycle of compounds (increase market size and share) by addressing significant unmet clinical needs of injectable macro- and small molecules through the use of its Transient Permeability Enhancer (TPE) platform.
+972 2-571-5885
Key People
Management
Board of Directors
Funding
| Date | Type | Capital Amount | Post-Money Valuation | Investors |
|---|---|---|---|---|
| 01/2009 | Series B | 11M | Unknown |
Products
| Name: | The TPE Platform |
| Product URL: | http://chiasmapharma.com/pipeline-research/ |
| Description: | Chiasma’s proprietary Transient Permeability Enhancer (TPE) platform enables oral delivery of macromolecules and poorly absorbed small molecules into the bloodstream with therapeutically relevant bioavailability. The TPE technology is versatile, can be applied to a wide range of therapeutic agents, requires no chemical modification of the drug and is cost effective. |
| Screenshots: |
|
Competitors
Profile
OpinionsRelated Companies
User Opinions
Bulls vs. Bears (0)
| Bullish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to succeed | ||||
| Bearish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to stumble. | ||||
Discussions (0)
Start a New Discussion
Opinion Poll
View All Opinions »Overall, are you bullish or bearish on Chiasma?
0 votes
0 votes
Vote to see results or
Similar Companies
View All Similar »Web Metrics
View All Web Metrics »
| Alexa Rank: | n/a |  |
n/a |
| Yahoo Search Results: | n/a | ||
Chiasma on Twitter
Twitter Search »Discussions
View All Discussions »There are no discussions right now.
Recent Contributors
There are no recent contributors to this company.
Related Jobs
loading...
Jobs
by
SimplyHired